EVIDENCE LIBRARY
Fragile-X Mouse Study Distinguished Diazepam’s Synaptic Effects From Neurosteroid Effects on Tonic Inhibition
A receptor-physiology study measured different forms of inhibition in mutant mice. Sharing a GABA-A target did not make diazepam and neurosteroids functionally interchangeable.
A receptor-physiology study measured different forms of inhibition in mutant mice. Sharing a GABA-A target did not make diazepam and neurosteroids functionally interchangeable.
The laboratory findings
Dentate granule cells from young Fmr1-knockout mice had reduced tonic inhibitory currents and altered spontaneous synaptic currents. Diazepam prolonged synaptic-current decay in both mutant and wild-type preparations.
Neuroactive steroids produced a sustained increase in tonic current in the mutant preparation, with evidence involving protein kinase C and receptor-related changes.
Different endpoints
A synaptic-current decay measurement is not the same as a persistent tonic-current change. Neither alone establishes improvements in human cognition, autism-related function, or seizure frequency.
The experiments involved a genetic mouse model and cellular recordings, not a clinical comparison of medicines in patients with fragile X syndrome. Mechanistic overlap therefore cannot establish clinical equivalence or predict the same adverse effects. The paper is useful for explaining why receptor subtype, cellular location, and signaling pathway matter when discussing a broad phrase such as increased GABA inhibition.
Source paper
Original analysis of the supplied journal article, identified as PMC6371020.